Company Profile
Public information reviewed
OCULAR THERAPEUTIX, INC
Canonical company identity and public leadership record.
USNASDAQ: OCUL
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 21
- Last reviewed
- Sep 13, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/ocular-therapeutix-inc.mdOCULAR THERAPEUTIX, INC
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:f3760c45-03c0-435e-aa9e-dee2d99db253 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/ocular-therapeutix-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 24 |
| Claims under review | 1 |
| Evidence records | 3 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-13T04:45:53.225961+00:00 |
| Last reviewed | 2026-09-13T04:45:53.225961+00:00 |
Identity
- Legal name: OCULAR THERAPEUTIX, INC
- Display name: OCULAR THERAPEUTIX, INC
Leadership
- Pravin U. Dugel, M.D.: Executive Chairman, President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Adrienne L. Graves: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3.
- Adrienne L. Graves, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Charles Warden: Lead Independent Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Jeffrey Heier, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3.
- Leslie J. Williams: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3.
- Merilee Raines: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3.
- Richard L. Lindstrom: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3.
- Richard L. Lindstrom, M.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Seung Suh Hong: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3.
- Seung Suh Hong, Ph.D.: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- David Robinson: Global Chief Commercial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Donald Notman: Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Jason Robins: Interim Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Jeffrey Heier, M.D.: Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Nadia Waheed, M.D.: Chief Medical Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Namrata Saroj, OD: Chief Business Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Peter K. Kaiser, M.D.: Chief Development Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Pravin U. Dugel, M.D.: Executive Chairman, President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Sanjay Nayak, M.B.B.S., Ph.D.: Chief Strategy Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
- Todd D.C. Anderman: Chief Legal Officer and Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- OCULAR THERAPEUTIX, INC. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:1: Alpha canonical company public projection.
- alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:2: SEC DEF 14A 0001104659-26-053176.
- alpha:evidence:company:f3760c45-03c0-435e-aa9e-dee2d99db253:3: DEF 14A ocul-20260611xdef14a.htm.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/ocular-therapeutix-incat https://mcp.alpha.ac/mcp